Previous Article | Next Article ![]()
Infection and Immunity, July 1999, p. 3641-3644, Vol. 67, No. 7
Institut de Pharmacologie Moléculaire
et Cellulaire, 06560 Valbonne, France
Received 16 February 1999/Returned for modification 19 March
1999/Accepted 14 April 1999
Leishmania major induces the rapid production of
interleukin-4 (IL-4) in both susceptible BALB/c and resistant
B10.D2 mice. In both strains, IL-4 is produced by T cells which react
to the parasite LACK (for Leishmania homolog of the
receptor for activated C kinase) antigen. The rapid
production of IL-4 in B10.D2 mice does not confer susceptibility but
results in increased parasite burdens.
Susceptibility of BALB/c mice to the
intracellular parasite Leishmania major is associated
with a strong Th2 response (17). In contrast, resistance of
other strains correlates with a Th1 response. Since interleukin-4
(IL-4) is required for the differentiation of naive T lymphocytes
into Th2 effector cells (23), the role of this cytokine in
susceptibility was studied extensively. Although early experiments
have shown that BALB/c mice treated with neutralizing anti-IL-4
monoclonal antibodies (MAbs) at the time of infection developed a
protective Th1 response and healed (21), recent results with mutant strains were more difficult to interpret. Thus, while IL-4-deficient BALB/c mice were resistant to L. major in one study (9), BALB/c mice carrying a similar
mutation remained susceptible in another one (15).
Other investigators have undertaken a detailed analysis of the early
production of IL-4 in resistant and susceptible strains. It was
previously shown that the amount of IL-4 mRNA induced by L. major 4 days after infection does not predict susceptibility or resistance (19, 22). In contrast, an 8- to 10-fold
increase in the amount of IL-4 transcripts was detected 16 h after
infection in susceptible BALB/c mice but not in resistant C57BL/6,
C3H/He, and CBA mice (12). This early peak of IL-4 was not
detected in BALB/c mice made resistant to L. major by the
administration of gamma interferon (IFN- Early accumulation of IL-4 mRNA in mice infected with
L. major.
In the first experiment, we infected
susceptible BALB/c and BALB.B mice and resistant B10.D2 and C57BL/6
mice with 107 L. major (strain
WHOM/IR/
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
CD4+ T Cells Which React to the Leishmania
major LACK Antigen Rapidly Secrete Interleukin-4 and Are
Detrimental to the Host in Resistant B10.D2 Mice
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
) or IL-12 (12).
In contrast, early IL-4 production was found in C57BL/6 mice made
susceptible by treatment with anti-IFN-
MAbs (12). To
further investigate the causal relationship between the rapid
accumulation of IL-4 transcripts induced by L. major
and susceptibility, we compared the early production levels of IL-4 in
BALB/c and B10.D2 mice, which have the same major histocompatibility
complex (MHC) d haplotype but differ in their susceptibility
to infection. We also performed similar studies with susceptible BALB.B
and resistant C57BL/6 mice, which have the same MHC b haplotype.
/173) stationary-phase promastigotes. Draining lymph nodes
(LN) were removed 20 h after infection and analyzed for the
presence of IL-4 mRNA by reverse transcription-PCR as described
previously (18). In agreement with previous reports (12), we found that L. major induced the
early accumulation of IL-4 mRNA in BALB/c but not in C57BL/6
mice (Fig. 1A). An early burst of IL-4
mRNA was also observed in BALB.B mice. However, in comparison to
the six- to sevenfold increase in the amount of IL-4 mRNA found in
BALB/c mice, the burst exhibited by BALB.B mice was smaller.
Unexpectedly, L. major also induced the accumulation of
IL-4 mRNA in resistant B10.D2 mice. Thus, although the early production of IL-4 may be necessary for susceptibility, it is clearly
not sufficient. Accordingly, resistance was found to be under the
control of several genes (1, 20) and independently determined by both T-cell and non-T-cell compartments (24).

View larger version (22K):
[in a new window]
FIG. 1.
Early accumulation of IL-4 mRNA in susceptible and
resistant mice infected with L. major. Mice of the
indicated inbred strains (A) or IE-LACK transgenic mice and their
negative littermates on the indicated background (B) were infected
(solid bars) or not (empty bars) with 107 L. major promastigotes. RNA was extracted from the draining LN
20 h after infection, and the relative levels of IL-4 mRNA
were determined by semiquantitative reverse transcription-PCR. Data are
means for two individual mice per group and are expressed in arbitrary
units. Data are representative of three different experiments.
LACK-specific T cells are responsible for the rapid production of
IL-4 induced by L. major in both BALB/c and B10.D2
mice.
Launois et al. have shown that the CD4+ T cells
which rapidly secrete IL-4 in BALB/c mice express V
8 and V
4
(11). Since CD4+ T cells which react to the
parasite LACK (for Leishmania homolog of the receptor for
activated C kinase) antigen also express V
8 and V
4, it was
proposed that these T cells were responsible for the early production
of IL-4 in this strain (11). In order to further investigate
this hypothesis, IE-LACK transgenic mice that were tolerant to LACK as
the result of the transgenic expression of this antigen in the thymus
(8) were backcrossed for 11 generations onto the BALB/c
and B10.D2 backgrounds, respectively. IE-LACK transgenic mice and their
negative littermates were infected with L. major and
analyzed 20 h later for expression of IL-4 mRNA in their
draining LN. As expected, L. major induced a five- to
sevenfold increase in the amount of IL-4 mRNA in IE-LACK-negative
littermates. As already observed for mice of inbred strains (Fig. 1A),
the amount of IL-4 mRNA induced by the parasite was slightly higher in B10.D2- than in BALB/c-derived mice. In contrast, no IL-4 burst was found in IE-LACK transgenic mice, whether they were on the BALB/c or B10.D2 background (Fig. 1B). Thus, LACK-specific T cells were responsible for the very rapid production of IL-4 that was induced
by L. major in both BALB/c and B10.D2 strains.
LACK-specific T cells express a Th2 phenotype in both
BALB/c and B10.D2 mice.
We have previously shown that
LACK-specific T cells express a Th2 phenotype in BALB/c mice
(8). Since LACK-specific T cells rapidly secrete IL-4 in
B10.D2 mice, we expected that these T cells would also express a Th2
phenotype in this latter strain. To investigate this hypothesis, B10.D2
and control BALB/c mice were infected with 2 × 106 L. major promastigotes. Six days after
infection, CD4+ T cells were purified from the draining LN
by negative selection by using sheep anti-rat antibody-coated Dynabeads
as described previously (16). A total of 5 × 105 purified CD4+ T cells were incubated in
vitro with 5 × 105 mitomycin C-treated syngeneic
splenocytes with or without an optimal concentration of LACK (amino
acids 158 to 173; FSPSLEHPIVVSGSWD)- or GP63 (amino acids
364 to 378; GSCTQRASEAHASLL)-derived peptides (8,
25). Supernatants were collected 48 h later, and cytokine contents were measured by enzyme-linked immunosorbent assay as described previously (8). In contrast to T cells from naive mice which did not secrete any detectable amount of IL-4, IL-5, or
IFN-
when stimulated with LACK or GP63 peptides (data not shown),
cells from both BALB/c and B10.D2 infected mice secreted high
levels of IL-4 and IL-5 but almost no IFN-
in response to the LACK
peptide (Fig. 2). In contrast, T cells
from both strains secreted IFN-
but no IL-4 or IL-5 when stimulated
with the GP63 peptide (Fig. 2). Thus, our data suggest that the nature
of the early T-cell responses directed to individual parasite
determinants depends mainly on the epitopes themselves, with non-MHC
determinants playing a limited role. This is in contrast to the
tendency of B10.D2 and BALB/c mice to mount polarized Th1 and Th2
responses, respectively. However, it was proposed that this latter
phenomenon was linked to differences in the ability of BALB/c and
B10.D2 mouse T cells to maintain responsiveness to IL-12, a phenotype which is controlled by a single locus on murine chromosome 11 (5-7). Since infection with L. major is
characterized by the delayed induction of IL-12, the fact that the
genetic background of the strain does not influence the development of
these early-activated T cells could be explained.
|
B10.D2 mice made tolerant to LACK develop smaller lesions and
exhibit decreased Th2 responses in comparison to their negative
littermates.
Since IL-4 is critical for the development of
counterprotective Th2 cells, we sought to determine whether the early
production of IL-4 which was induced by L. major in
B10.D2 mice would regulate the immune response directed toward the
parasite. To this end, IE-LACK transgenic mice on the B10.D2 background
and their negative littermates were infected with L. major and the thickness of the infected footpads was monitored
with a metric caliper. We found that IE-LACK transgenic mice developed
smaller lesions than their negative littermates (Fig.
3A). These differences correlated with reduced parasite burdens in the draining LN and in the footpads, as
determined 5 weeks after infection by limiting dilution analysis (26) (Fig. 3B). The increased ability of IE-LACK transgenic mice to heal correlated with a 20-fold reduction in the number of
IL-4-secreting parasite-specific T cells in their draining LN, as
measured by an enzyme-linked immunosorbent spot (ELISPOT) assay
following in vitro stimulation with soluble leishmania antigens (SLA)
(Fig. 3C). In contrast, the numbers of IFN-
- and IL-5-secreting cells were not significantly different in IE-LACK transgenic mice and
in their negative littermates. Thus, the early production of IL-4 by
LACK-specific T cells in B10.D2 mice was not sufficient to confer
susceptibility, but it could impair their ability to eliminate the
parasite. A similar phenomenon was observed in genetically resistant
transgenic mice in which IL-4 was expressed by B cells and in B10.D2
mice infected with an adenovirus carrying the IL-4 gene (3,
14). The counterprotective role of IL-4 in these resistant
strains could be explained by the ability of this cytokine to
downregulate the antimicrobial activity of the macrophages or to reduce
T-cell responsiveness to IL-12 (13).
|
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Association pour la Recherche contre le Cancer (ARC) and the Ministère de l'Education Nationale de la Recherche et de l'Enseignement Supérieur. V.J. was supported by a fellowship from the Ligue Nationale contre le Cancer (LNCC).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Groupement de Recherche en Parasitologie (GDR), 660 Route des Lucioles, 06560 Valbonne, France. Phone: 33 4 93 95 77 85. Fax: 33 4 93 95 77 08. E-mail: glaichenhaus{at}ipmc.cnrs.fr.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Beebe, A. M., S. Mauze, N. J. Schork, and R. L. Coffman. 1997. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551-557[Medline]. |
| 2. |
Constant, S.,
C. Pfeiffer,
A. Woodard,
T. Pasqualini, and K. Bottomly.
1995.
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells.
J. Exp. Med.
182:1591-1596 |
| 3. |
Gabaglia, C. R.,
B. Pedersen,
M. Hitt,
N. Burdin,
E. E. Sercarz,
F. L. Graham,
J. Gauldie, and T. A. Braciak.
1999.
A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
J. Immunol.
162:753-760 |
| 4. | Gajewski, T. F., M. Pinnas, T. Wong, and F. W. Fitch. 1991. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol. 146:1750-1759[Abstract]. |
| 5. |
Gorham, J. D.,
M. L. Güler,
R. G. Steen,
A. J. Mackey,
M. J. Daly,
K. Frederick,
W. F. Dietrich, and K. M. Murphy.
1996.
Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses.
Proc. Natl. Acad. Sci. USA
93:12467-12472 |
| 6. | Güler, M. L., J. D. Gorham, C.-S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 development. Science 271:984-987[Abstract]. |
| 7. |
Güler, M. L.,
N. G. Jacobson,
U. Gubler, and K. M. Murphy.
1997.
T cell genetic background determines maintenance of IL-12 signaling effects on BALB/c and B10.D2 T helper cell type 1 phenotype development.
J. Immunol.
159:1767-1774[Abstract].
|
| 8. |
Julia, V.,
M. Rassoulzadegan, and N. Glaichenhaus.
1996.
Resistance to Leishmania major induced by tolerance to a single antigen.
Science
274:421-423 |
| 9. |
Kopf, M.,
F. Brombacher,
G. Köhler,
G. Krienzle,
K.-H. Widmann,
K. Lefrang,
C. Humborg,
B. Ledermann, and W. Solbach.
1996.
IL-4-deficient BALB/c mice resist infection with Leishmania major.
J. Exp. Med.
184:1127-1136 |
| 10. |
Kumar, V.,
V. Bhardwaj,
V. Soares,
J. Alexander,
A. Sette, and E. Sercarz.
1995.
Major histocompatibility complex affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon- by T cells.
Proc. Natl. Acad. Sci. USA
92:9510-9514 |
| 11. |
Launois, P.,
I. Maillard,
S. Pingel,
K. G. Swihart,
I. Xenarios,
H. AchaOrbea,
H. Diggelmann,
R. M. Locksley,
H. R. MacDonald, and J. A. Louis.
1997.
IL-4 rapidly produced by V 4 V 8 CD4+ T cells instructs the development and susceptibility to Leishmania major in BALB/c mice.
Immunity
6:541-549[Medline].
|
| 12. |
Launois, P.,
T. Ohteki,
K. Swihart,
H. R. MacDonald, and J. A. Louis.
1995.
In susceptible mice, Leishmania major induces very rapid interleukin-4 production by CD4+ T cells which are NK1.1 .
Eur. J. Immunol.
25:3298-3307[Medline].
|
| 13. | Launois, P., K. G. Swihart, G. Milon, and J. A. Louis. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317-3324[Abstract]. |
| 14. | Leal, L. M. C. C., D. W. Moss, R. Kuhn, W. Muller, and F. Y. Liew. 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23:566-569[Medline]. |
| 15. | Noben-Trauth, N., P. Kropf, and I. Müller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271:987-989[Abstract]. |
| 16. | Powrie, F., M. W. Leach, S. Mauze, S. Menon, L. B. Caddle, and R. L. Coffman. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1:553-562[Medline]. |
| 17. | Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177[Medline]. |
| 18. | Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37-46[Medline]. |
| 19. |
Reiner, S. L.,
S. Zheng,
Z.-E. Wang,
L. Stowring, and R. M. Locksley.
1994.
Leishmania promastigotes evade interleukin-12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
J. Exp. Med.
179:447-456 |
| 20. |
Roberts, L. J.,
T. M. Baldwin,
J. M. Curtis,
E. Handman, and S. J. Foote.
1997.
Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9.
J. Exp. Med.
185:1705-1710 |
| 21. |
Sadick, M. D.,
F. P. Heinzel,
B. J. Holoway,
R. T. Pu,
R. Dawkins, and R. M. Locksley.
1990.
Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody.
J. Exp. Med.
171:115-127 |
| 22. | Scott, P., A. Eaton, W. C. Gause, X. Zhou, and B. Hondowicz. 1996. Early IL-4 production does not predict susceptibility to Leishmania major. Exp. Parasitol. 84:178-187[Medline]. |
| 23. |
Seder, R. A.,
W. E. Paul,
M. M. Davis, and B. Fazekas de St. Groth.
1992.
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.
J. Exp. Med.
176:1091-1098 |
| 24. |
Shankar, A. H., and R. G. Titus.
1995.
T cell and non-T cell compartments can independently determine resistance to Leishmania major.
J. Exp. Med.
181:845-855 |
| 25. |
Soarez, L. R. B.,
E. E. Sercarz, and A. Miller.
1994.
Vaccination of the Leishmania major susceptible BALB/c mouse. I. The precise selection of peptide determinant influences CD4+ T cell subset expression.
Int. Immunol.
6:785-794 |
| 26. |
Stenger, S.,
N. Donhauser,
H. Thüring,
M. Röllinghoff, and C. Bogdan.
1996.
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
J. Exp. Med.
183:1501-1514 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|